Genetic SNP profiling

GENETIC2 trials

Sponsors

Institute of Cancer Research, United Kingdom

Conditions

Prostate Cancer

Unknown Phase

The BARCODE 1 Pilot Study

Active, not recruitingNCT03158922

Institute of Cancer Research, United KingdomProstate Cancer

Start: 2016-04-29End: 2028-12-31Updated: 2025-09-26

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

Active, not recruitingNCT03857477

Institute of Cancer Research, United KingdomProstate Cancer

Start: 2019-03-14End: 2028-12-31Updated: 2025-04-29

Related Papers

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer

Hereditary Cancer in Clinical Practice2026-07-15

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer

New England Journal of Medicine2025-04-0940 citations

Effect of polygenic risk score for clinically significant prostate cancer in a screening program: The BARCODE 1 study results.

Journal of Clinical Oncology2024-06-0111 citations

The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.

Journal of Clinical Oncology2022-02-166 citations